AbbVie to Present at Wells Fargo Healthcare Conference Sept. 9, 2026
AbbVie will take part in the Wells Fargo 21st Annual Healthcare Conference on September 9, 2026, highlighting future plans in immunology, neuroscience, oncology, and aesthetics. A live fireside chat is scheduled for 9:15 a.m. Central time, with an archived version of the presentation available later the same day. The company is also seeking EMA approval for subcutaneous SKYRIZI to treat Crohn’s disease in adults.